Top Small Cap Stocks To Consider - September 7th

Key Points

• MarketBeat identified seven small-cap stocks to watch based on recent dollar trading volume: ProShares UltraPro Short QQQ, GoPro, Inflection Point Acquisition Corp. II, AltC Acquisition, bioAffinity Technologies, Immuron, and Spring Valley Acquisition.
• ProShares UltraPro Short QQQ seeks daily returns equal to three times the inverse of the Nasdaq-100, making it a leveraged bearish tool rather than a traditional small-cap operating company.
• The list spans consumer technology and biotech companies, including GoPro, bioAffinity Technologies, and Immuron, alongside several acquisition companies; the article cautions that small-cap stocks generally involve higher volatility, lower liquidity, and greater business risk.

ProShares UltraPro Short QQQ, GoPro, Inflection Point Acquisition Corp. II, AltC Acquisition, bioAffinity Technologies, Immuron, and Spring Valley Acquisition are the seven Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of companies with relatively small market capitalizations, typically ranked below large- and mid-cap companies, though exact size thresholds vary by market and index provider. They may offer greater growth potential but generally carry higher risks, including greater price volatility, lower liquidity, and less-established business operations. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Read Our Latest Research Report on SQQQ

GoPro (GPRO)

GoPro, Inc. develops and sells cameras, mountable and wearable accessories, and subscription services and software in the Americas, Europe, the Middle East, Africa, the Asia and Pacific region, and internationally. The company provides cloud connected HERO12 Black, HERO11 Black, HERO11 Black Mini, HERO10 Black, HERO10 Black Bones, and HERO9 Black waterproof cameras; MAX, a 360-degree waterproof camera; Premium and Premium+ subscription services, which include full access to the Quik app, cloud storage supporting source video and photo quality, camera replacement, and damage protection; Quik subscription that offers access to editing tools, which allows users to edit photos, videos, and create cinematic stories; and Quik desktop and mobile apps that enable users to get their favorite photos and videos with footage from any phone or camera.

Read Our Latest Research Report on GPRO

Inflection Point Acquisition Corp. II (IPXX)

Read Our Latest Research Report on IPXX

AltC Acquisition (ALCC)

AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.

Read Our Latest Research Report on ALCC

bioAffinity Technologies (BIAF)

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.

Read Our Latest Research Report on BIAF

Immuron (IMRN)

Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious and immune modulated diseases in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products.

Read Our Latest Research Report on IMRN

Spring Valley Acquisition (SV)

Read Our Latest Research Report on SV

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.